Filing Flows

Filing Flows › Companies › Gilead Sciences › Timeline

Gilead Sciences stock timeline

A year of the price with every insider trade, planned sale, earnings report and material 8-K marked

252 sessions+38.6% to $166.89

Gilead Sciences (GILD) stock rose 39% over the last 252 sessions, to $166.89. On the way it reported 4 quarters, its insiders filed no open-market trades (10b5-1 plan sales aside) and 14 Form 144 notices of planned sales, and the company filed 3 material 8-Ks. Each is marked on the price and listed with what the stock did next.

GILD: a year of the stock with every disclosure on itGILD: a year of the stock with every disclosure on it$128$145$162$179◆2025-11-19 · Directors and officers: departures, appointments, pay●2026-02-10 · Earnings: beat the EPS estimate by 2.8%◆2026-02-23 · Material definitive agreement●2026-05-07 · Earnings: beat the EPS estimate by 6.2%◆2026-05-20 · Material definitive agreement▽2026-07-15 · Form 144: Johanna Mercier plans to sell $390K▽2026-07-15 · Form 144: Andrew Dickinson plans to sell $390K▽2026-08-03 · Form 144: Daniel O'Day plans to sell $7.2M●2026-08-04 · Earnings: beat the EPS estimate by 6.9%▽2026-08-17 · Form 144: Johanna Mercier plans to sell $3.9M▽2026-08-17 · Form 144: Andrew Dickinson plans to sell $415K▽2026-08-20 · Form 144: Jeffrey Bluestone plans to sell $738K▽2026-08-26 · Form 144: Anthony Welters plans to sell $2.7M▽2026-09-15 · Form 144: Johanna Mercier plans to sell $433K▽2026-09-15 · Form 144: Andrew Dickinson plans to sell $436K▽2026-10-15 · Form 144: Johanna Mercier plans to sell $469K▽2026-10-15 · Form 144: Andrew Dickinson plans to sell $469K●2026-10-29 · Earnings: beat the EPS estimate by 16.2%▽2026-10-30 · Form 144: Daniel O'Day plans to sell $7.6M▽2026-11-04 · Form 144: Daniel O'Day plans to sell $18.8M▽2026-11-06 · Form 144: Keeley M Cain Wettan plans to sell $570K◆8-K event●Earnings report▽Planned sale (Form 144)2025-11-062026-11-06
Daily closes, Nov 6, 2025 to Nov 6, 2026; hover a mark for the filing.

Each mark, and what followed

DateKindWhatNext session5 sessions21 sessions
Nov 6, 2026Form 144Form 144: Keeley M Cain Wettan plans to sell $570K−0.4% (−0.7% vs SPY)——
Nov 4, 2026Form 144Form 144: Daniel O'Day plans to sell $18.8M+4.1% (+2.5% vs SPY)——
Oct 30, 2026Form 144Form 144: Daniel O'Day plans to sell $7.6M+3.0% (+4.8% vs SPY)+1.2% (+6.0% vs SPY)—
Oct 29, 2026EarningsEarnings: beat the EPS estimate by 16.2%+4.0% (+4.3% vs SPY)+9.2% (+9.9% vs SPY)—
Oct 15, 2026Form 144Form 144: Andrew Dickinson plans to sell $469K+2.5% (+2.2% vs SPY)0.0% (−0.4% vs SPY)—
Oct 15, 2026Form 144Form 144: Johanna Mercier plans to sell $469K+2.5% (+2.2% vs SPY)0.0% (−0.4% vs SPY)—
Sep 15, 2026Form 144Form 144: Andrew Dickinson plans to sell $436K+0.5% (+1.0% vs SPY)+3.4% (+1.5% vs SPY)+1.6% (−0.9% vs SPY)
Sep 15, 2026Form 144Form 144: Johanna Mercier plans to sell $433K+0.5% (+1.0% vs SPY)+3.4% (+1.5% vs SPY)+1.6% (−0.9% vs SPY)
Aug 26, 2026Form 144Form 144: Anthony Welters plans to sell $2.7M−0.5% (−0.5% vs SPY)+0.8% (+1.3% vs SPY)+1.1% (+0.7% vs SPY)
Aug 20, 2026Form 144Form 144: Jeffrey Bluestone plans to sell $738K−2.9% (−2.0% vs SPY)+0.3% (+0.7% vs SPY)+2.2% (+2.9% vs SPY)
Aug 17, 2026Form 144Form 144: Andrew Dickinson plans to sell $415K+0.4% (+0.9% vs SPY)+5.4% (+6.8% vs SPY)+6.1% (+8.6% vs SPY)
Aug 17, 2026Form 144Form 144: Johanna Mercier plans to sell $3.9M+0.4% (+0.9% vs SPY)+5.4% (+6.8% vs SPY)+6.1% (+8.6% vs SPY)
Aug 4, 2026EarningsEarnings: beat the EPS estimate by 6.9%+3.1% (+1.3% vs SPY)+1.5% (−0.6% vs SPY)+13.4% (+12.8% vs SPY)
Aug 3, 2026Form 144Form 144: Daniel O'Day plans to sell $7.2M+0.7% (−0.7% vs SPY)+2.3% (−1.2% vs SPY)+11.7% (+9.0% vs SPY)
Jul 15, 2026Form 144Form 144: Andrew Dickinson plans to sell $390K+1.3% (+0.9% vs SPY)+0.2% (+0.6% vs SPY)+4.4% (+1.7% vs SPY)
Jul 15, 2026Form 144Form 144: Johanna Mercier plans to sell $390K+1.3% (+0.9% vs SPY)+0.2% (+0.6% vs SPY)+4.4% (+1.7% vs SPY)
May 20, 20268-KMaterial definitive agreement−0.2% (−0.3% vs SPY)+4.1% (+2.4% vs SPY)−3.9% (−4.6% vs SPY)
May 7, 2026EarningsEarnings: beat the EPS estimate by 6.2%−1.7% (−1.4% vs SPY)−2.4% (−3.6% vs SPY)−5.4% (−5.9% vs SPY)
Feb 23, 20268-KMaterial definitive agreement−1.0% (0.0% vs SPY)−1.6% (−1.1% vs SPY)−9.2% (−4.4% vs SPY)
Feb 10, 2026EarningsEarnings: beat the EPS estimate by 2.8%−3.0% (−2.7% vs SPY)+2.4% (+4.0% vs SPY)−3.8% (−1.2% vs SPY)
Nov 19, 20258-KDirectors and officers: departures, appointments, pay+0.7% (+0.3% vs SPY)0.0% (−2.3% vs SPY)−3.9% (−6.4% vs SPY)

What this kind of 8-K usually did

Item8-KsNext session, medianUp next session21 sessions, medianTypical size
5.02 Directors and officers: departures, appointments, pay39,174−0.1%48%+0.7%±1.4%
1.01 Material definitive agreement23,5250.0%51%+1.0%±1.4%
2.03 New debt or off-balance-sheet obligation13,2680.0%50%+1.2%±1.3%

Across every company in the move-odds universe, measured from the close before the filing. Every 8-K item ranked →

Report card: every quarter against the estimate → Gilead Sciences: every quarter → Live insider trades →

Prices are daily closes; filings and trades are as filed with the SEC (Form 4 within two business days of the trade, 8-K within four of the event). Moves after a mark are the stock's close-to-close change and the same for SPY; they describe the record, not what the next one will do. Not investment advice.